SLM + Axitinib for Clear Cell RCC
Clinical trial NCT02535533 · COMPLETED
Trial details
- NCT number
- NCT02535533
- Sponsor
- Mohammed Milhem
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2023-08-22
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.